AGIO logo

Agios Pharmaceuticals (AGIO) Cash From Investing

Annual CFI

$363.44 M
+$123.87 M+51.70%

December 31, 2024


Summary


Performance

AGIO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAGIOcash flowmetrics:

Quarterly CFI

-$49.16 M
-$299.95 M-119.60%

December 31, 2024


Summary


Performance

AGIO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAGIOcash flowmetrics:

TTM CFI

$363.44 M
-$144.67 M-28.47%

December 31, 2024


Summary


Performance

AGIO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAGIOcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AGIO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+51.7%-151.5%+51.7%
3 y3 years-70.9%-151.5%+51.7%
5 y5 years+297.5%-151.5%+51.7%

AGIO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.9%+51.7%-119.6%+47.9%-70.9%+155.8%
5 y5-year-70.9%+379.8%-102.6%+83.5%-80.3%+155.8%
alltimeall time-70.9%+209.0%-102.6%+83.5%-80.3%+155.8%

Agios Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
$363.44 M(+51.7%)
-$49.16 M(-119.6%)
$363.44 M(-28.5%)
Sep 2024
-
$250.79 M(+573.4%)
$508.11 M(+71.3%)
Jun 2024
-
$37.24 M(-70.1%)
$296.66 M(-3.2%)
Mar 2024
-
$124.56 M(+30.4%)
$306.54 M(+28.0%)
Dec 2023
$239.57 M(-1.5%)
$95.51 M(+142.8%)
$239.57 M(+5.5%)
Sep 2023
-
$39.34 M(-16.5%)
$227.01 M(-22.2%)
Jun 2023
-
$47.13 M(-18.2%)
$291.74 M(-10.9%)
Mar 2023
-
$57.60 M(-30.6%)
$327.43 M(+34.6%)
Dec 2022
$243.26 M(-80.5%)
$82.95 M(-20.3%)
$243.26 M(+269.2%)
Sep 2022
-
$104.07 M(+25.7%)
$65.89 M(-124.3%)
Jun 2022
-
$82.81 M(-411.6%)
-$270.91 M(-58.4%)
Mar 2022
-
-$26.57 M(-71.9%)
-$651.87 M(-152.2%)
Dec 2021
$1.25 B(+1548.6%)
-$94.42 M(-59.4%)
$1.25 B(-11.7%)
Sep 2021
-
-$232.73 M(-21.9%)
$1.41 B(-7.0%)
Jun 2021
-
-$298.15 M(-115.9%)
$1.52 B(-17.4%)
Mar 2021
-
$1.87 B(+2524.9%)
$1.84 B(+2331.4%)
Dec 2020
$75.75 M(-17.2%)
$71.40 M(-156.6%)
$75.75 M(-142.0%)
Sep 2020
-
-$126.24 M(-662.1%)
-$180.42 M(-788.6%)
Jun 2020
-
$22.46 M(-79.2%)
$26.20 M(-61.6%)
Mar 2020
-
$108.14 M(-158.5%)
$68.22 M(-25.4%)
Dec 2019
$91.44 M(-133.4%)
-$184.77 M(-329.9%)
$91.44 M(-65.3%)
Sep 2019
-
$80.38 M(+24.7%)
$263.41 M(+41.8%)
Jun 2019
-
$64.48 M(-50.9%)
$185.80 M(+641.4%)
Mar 2019
-
$131.35 M(-1125.8%)
$25.06 M(-109.2%)
Dec 2018
-$273.82 M
-$12.80 M(-562.1%)
-$273.82 M(+24.9%)
Sep 2018
-
$2.77 M(-102.9%)
-$219.17 M(+40.9%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$96.26 M(-42.5%)
-$155.53 M(-53.6%)
Mar 2018
-
-$167.53 M(-500.3%)
-$334.99 M(+478.5%)
Dec 2017
-$57.91 M(-51.5%)
$41.85 M(-37.0%)
-$57.91 M(-67.3%)
Sep 2017
-
$66.42 M(-124.1%)
-$177.27 M(-42.1%)
Jun 2017
-
-$275.73 M(-351.7%)
-$306.44 M(-6192.1%)
Mar 2017
-
$109.55 M(-241.3%)
$5.03 M(-104.2%)
Dec 2016
-$119.35 M(-193.0%)
-$77.52 M(+23.5%)
-$119.35 M(+471.8%)
Sep 2016
-
-$62.74 M(-275.6%)
-$20.87 M(-129.0%)
Jun 2016
-
$35.74 M(-341.0%)
$72.03 M(+5.2%)
Mar 2016
-
-$14.83 M(-170.8%)
$68.49 M(-46.6%)
Dec 2015
$128.31 M(-138.5%)
$20.96 M(-30.5%)
$128.31 M(-171.3%)
Sep 2015
-
$30.16 M(-6.4%)
-$179.95 M(-20.1%)
Jun 2015
-
$32.21 M(-28.4%)
-$225.21 M(-18.4%)
Mar 2015
-
$44.99 M(-115.7%)
-$276.08 M(-17.2%)
Dec 2014
-$333.34 M(+282.2%)
-$287.30 M(+1802.9%)
-$333.34 M(+401.7%)
Sep 2014
-
-$15.10 M(-19.1%)
-$66.44 M(-49.7%)
Jun 2014
-
-$18.67 M(+52.2%)
-$132.07 M(+27.6%)
Mar 2014
-
-$12.27 M(-39.9%)
-$103.52 M(+18.7%)
Dec 2013
-$87.22 M(-478.5%)
-$20.41 M(-74.7%)
-$87.22 M(+85.7%)
Sep 2013
-
-$80.72 M(-917.1%)
-$46.97 M(-246.6%)
Jun 2013
-
$9.88 M(+144.8%)
$32.03 M(+91.9%)
Mar 2013
-
$4.04 M(-79.7%)
$16.69 M(-27.6%)
Dec 2012
$23.04 M(-203.1%)
$19.84 M(-1252.0%)
$23.04 M(+618.9%)
Sep 2012
-
-$1.72 M(-68.5%)
$3.21 M(-35.0%)
Jun 2012
-
-$5.46 M(-152.6%)
$4.93 M(-52.6%)
Mar 2012
-
$10.39 M
$10.39 M
Dec 2011
-$22.36 M
-
-

FAQ

  • What is Agios Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Agios Pharmaceuticals?
  • What is Agios Pharmaceuticals annual CFI year-on-year change?
  • What is Agios Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Agios Pharmaceuticals?
  • What is Agios Pharmaceuticals quarterly CFI year-on-year change?
  • What is Agios Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Agios Pharmaceuticals?
  • What is Agios Pharmaceuticals TTM CFI year-on-year change?

What is Agios Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of AGIO is $363.44 M

What is the all time high annual CFI for Agios Pharmaceuticals?

Agios Pharmaceuticals all-time high annual cash flow from investing activities is $1.25 B

What is Agios Pharmaceuticals annual CFI year-on-year change?

Over the past year, AGIO annual cash flow from investing activities has changed by +$123.87 M (+51.70%)

What is Agios Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of AGIO is -$49.16 M

What is the all time high quarterly CFI for Agios Pharmaceuticals?

Agios Pharmaceuticals all-time high quarterly cash flow from investing activities is $1.87 B

What is Agios Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, AGIO quarterly cash flow from investing activities has changed by -$144.67 M (-151.47%)

What is Agios Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of AGIO is $363.44 M

What is the all time high TTM CFI for Agios Pharmaceuticals?

Agios Pharmaceuticals all-time high TTM cash flow from investing activities is $1.84 B

What is Agios Pharmaceuticals TTM CFI year-on-year change?

Over the past year, AGIO TTM cash flow from investing activities has changed by +$123.87 M (+51.70%)